Coya Therapeutics (COYA) Return on Equity [ROE] (2023 - 2026)
Coya Therapeutics (COYA) posted Return on Equity [ROE] of -48.37% for Q2 2026, up 22.75 percentage points from -71.12% a year earlier but down 1.05 percentage points from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Coya Therapeutics' Return on Equity [ROE] came in at -51.39%, down 11.82 percentage points from FY2024.
- In prior years, Coya Therapeutics' Return on Equity [ROE] was -39.57% in FY2024 (+19.07 pp) and -58.64% in FY2023.
- Quarterly Return on Equity [ROE] has run from a low of -283.85% in Q1 2023 to a high of -28.65% in Q2 2024 over five years.
- On a year-over-year basis, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -4.53 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2024, with a gain of 254.29 percentage points; the weakest was Q2 2025, with a drop of 42.46 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -47.32% (Q1 2026), -62.20% (Q4 2025) and -71.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.64 Bn | 1,118.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 626.55 Bn | 545.08 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 498.79 Bn | 471.91 Bn | 12.70 Bn | - |
| 4 | Merck | 371.66 Bn | 326.04 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 299.96 Bn | 263.95 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 263.22 Bn | 236.91 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.03 Bn | 192.43 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.20 Bn | 165.40 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | 4.97% |
| 10 | Coya Therapeutics | 103.92 Mn | -64.96 Mn | - | -48.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.37% |
| Mar 31, 2026 | -47.32% |
| Dec 31, 2025 | -62.20% |
| Sep 30, 2025 | -71.64% |
| Jun 30, 2025 | -71.12% |
| Mar 31, 2025 | -51.35% |
| Dec 31, 2024 | -46.03% |
| Sep 30, 2024 | -31.45% |
| Jun 30, 2024 | -28.65% |
| Mar 31, 2024 | -29.56% |
| Dec 31, 2023 | -34.57% |
| Sep 30, 2023 | -100.46% |
| Jun 30, 2023 | -73.60% |
| Mar 31, 2023 | -283.85% |
API Access
Coya Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();